Despite the lack of material sales for the 6 months which we...

Despite the lack of material sales for the 6 months which we already knew about given the quarterly cash flow reports (Appendix 4C), there is certainly positives on the commercialisation program and potential sales front as disclosed in the Director's Report.  Please find these extracted below:

Validation

• Further validation sales of Bluechiip system with hospitals, biobanks, Laboratory Information Management System (LIMS) integrators and end-users in the United States, Europe, Asia and Australia. The feedback from these sales provides both feedback on the product usability and an input to further commercial activities.

Licensing and Distribution

• The establishment of a test and evaluation agreement with SIAD Group in Italy to integrate the Bluechiip Cryotag into SIAD’s cryobags which are used to store cord blood and other biological products;
• NPO Bio Bank Support Organisation to sell the Bluechiip product range for biobanking and other life science related markets in Japan;
• Glory Biotech Corp to sell the Bluechiip product range for biobanking and other life science related markets in Korea;
• Axon Scientific Sdn Bhd to sell the Bluechiip product range for biobanking and other life science related markets in Malaysia;
• Integrated Bio Ltd to sell the Bluechiip product range for biobanking and other life science related markets in Taiwan; and
• The Company continues to work with existing distributors such as Micronic America and MiTeGen and discussion on further potential commercial partnerships

Original Equipment Manufacturer (“OEM”) and Partnerships

• Manufacturing trials of the new vial, a result of the successful integration of Bluechiip MEMS tag with Micronic vial, as part of the co-development project with Micronic BV; and
• Important to developing future partnerships, Bluechiip has concentrated its effort on:
  
  • The development and miniaturisation of the MatchboxTM reader to provide portability; and
  • The development of a multi vial reader for demonstration at the SLAS meeting in Washington, USA in February 2015.

Here's hoping this converts ASAP to sales which will validate to the market (both investment and Bluechiip's customer base) that this is a genuine tracking and monitoring solution for this first market vertical.